Merit Medical Updates FY24 Adj. EPS From $3.25-$3.34 To $3.33-$3.38 Vs $3.30 Est.; Net Sales $1.339B-$1.351B To $1.344B-$1.352B Vs $1.344B Est.
Portfolio Pulse from Benzinga Newsdesk
Merit Medical has updated its FY24 adjusted EPS guidance from $3.25-$3.34 to $3.33-$3.38, surpassing the previous estimate of $3.30. The net sales forecast has been slightly adjusted to $1.344B-$1.352B, aligning with the previous estimate of $1.344B.
October 30, 2024 | 8:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical has increased its FY24 adjusted EPS guidance, which is now above the previous estimate. The net sales forecast has been slightly adjusted but remains in line with expectations.
The upward revision of the EPS guidance indicates stronger than expected profitability, which is likely to positively impact the stock price. The net sales forecast adjustment is minor and aligns with expectations, reinforcing the positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100